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cense (Lactobacillus and healthEvidence shows that Lactobacillus species are the dominant
vaginal bacteria in a majority of women, contributing to an
acidic environment (pH 3.5e4.5) in the vaginal area. Lacto-
bacillus also contributes to the production of hydrogen per-
oxide to inhibit overgrowth of other pathogens, including
group B streptococci, Escherichia coli, Staphyococcus aureus,
Gardnerella vaginalis, or other fastidious or uncultivated
anaerobes.1 Lactic acid, through the production of Lactoba-
cillus species, is a potent and broad-spectrum bactericide and
virucide. Therefore, many interventional efforts have been and
are being made to restore vaginal health through the applica-
tion of oral or vaginal probiotic formulations of Lactobacillus
species.2 In addition, the benefits of restoring vaginal micro-
biomes in women are not only related to the health status of
women themselves but also to obstetric outcomes when these
women get pregnant.3,4 Therefore, management, manipu-
lation, and restoration of a robust vaginal microbiota might be
advantageous in vastly improving women's health and disease
prevention.2 This is because historically, the presence of
Lactobacillus species has been thought to be the sine qua non
of healthy vaginal microbial communities in women during
the reproductive age,4 and it might also be useful in the pre-
vention of the benign or malignant lower genital tract diseases,
such as bacterial vaginosis, sexually transmitted disease, and
possible neoplasms, such as cervical intraepithelial neoplasm
or cervical cancers.5,6 However, a scientific level under-
standing of how the vaginal microbiota is associated with
obstetric, gynecological, and reproductive health remains
problematic and deficient. Furthermore, a big gap in the
development of effective preventive approaches to improved
women's health is that the normal distribution of Lactobacillus
species within the healthy vagina of women, especially in the
different geographic areas, is still uncertain. Actually, the
detailed information about the Lactobacillus species in the
vagina of healthy women in different geographic areas might
be one of the critical steps. Therefore, it is acknowledged that
all new information addressing this topic should be thoroughly
reviewed.7
The study by Mousavi et al8 in this issue of the Journal of
the Chinese Medical Association focused on this issue to
isolate and identify the Lactobacillus species in the vagina of
healthy Iranian women who live in the Ahvaz area. Thex.doi.org/10.1016/j.jcma.2016.05.002
901/Copyright © 2016, the Chinese Medical Association. Published by Else
http://creativecommons.org/licenses/by-nc-nd/4.0/).authors evaluated the 50 healthy women, and found that only
66% of those women were identified to have Lactobacillus
species, which included the most common form as Lactoba-
cillus crispatus (42.4%, n ¼ 14). The second-most common
form of Lactobacillus species was Lactobacillus rhamnosus
(27%, n ¼ 9), followed in order by Lactobacillus gasseri
(18.2%, n ¼ 6), and Lactobacillus salivarius and Lactobacillus
platntarum (both 6%, n ¼ 2).8 Furthermore, L. rhamnosus has
the most powerful capacity to attach two epithelia cell lines,
including Vero cells (African Green monkey kidney epi-
thelium) and HeLa cells (human squamous cell carcinoma
epithelium).8 This study is interesting and worthy of further
discussion.
First, it is not surprising to see the most frequently identi-
fied Lactobacillus species from the vagina of Iranian healthy
women as L. crispatus and L. gasseri,8 because it has been
reported that both species and another two unidentified species
by the authorsdLactobacillus iners and Lactobacillus jense-
nii, seem to be specific to the human vagina, where they lev-
erage a unique anaerobic nutritional environment to produce
copious amounts of lactic acid as a fermentation product,2
suggesting that the probiotic formulations of Lactobacillus
species marketing in Iran should include L. crispatus and L.
gasseri. A recent publication also supported the positive role
of L. crispatus in women’s health.9 L. crispatus-dominated
cervicovaginal microbiota is considered more beneficial than
L. iners-dominated cervicovaginal microbiota, because it is
less likely to shift to dysbiosis and is associated with lower
prevalence of sexually transmitted infections.9
Second, Mousavi et al's8 study was consistent with our
understanding that not all healthy reproductive-age women
have the presence of Lactobacillus species in their vagina
(only two-thirds of the women in the current study). It has
been reported that a large proportion of women lack appre-
ciable numbers of Lactobacillus species (10e42% of
women).2 In fact, these women who lack appreciable numbers
of Lactobacillus species are at risk for urogenital infection,
and can remain asymptomatic for bacterial vaginosis.
Third, it is important to find that L. rhamnosus attached
more readily to the epithelial cells, including cervical cancer
cell line (HeLa cells) than did the other Lactobacillus species.8
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vical cancer and the immunosuppressive tumor micro-
environment mediated by cytokines, which is indirectly
determined by vaginal microbeta. Audirac-Chalifour et al's5
study showed that human papillomavirus-negative women
had an elevated proportion of L. crispatus (46%) and a lesser
proportion of L. iners (14.9%), whereas human
papillomavirus-positive women had proportions of 13.3% and
2.1%, respectively. In addition, these proportions seemed to
switch with the presence of human papillomavirus, and L.
crispatus was found in smaller proportions in squamous
intraepithelial lesions (14.4%) and cervical cancers (1.3%),
whereas L. iners dropped to 2.1% in squamous intraepithelial
lesions and was totally absent in cervical cancers. It is also
noted that other species of Lactobacillus, L. jensenii and
Lactobacillus vaginalis, were found only in samples from
women with normal cytology from Papanicolaou smear.5 In an
early UK study, Mitra et al10 also found that increasing disease
severity of cervical intraepithelial neoplasia was associated
with a decreasing relative abundance of Lactobacillus species,
supporting the importance of Lactobacillus-dominated vaginal
microbiota for regulating human papillomavirus persistence
and progression of cervical intraepithelial neoplasia. Fur-
thermore, one study showed that L. crispatus and L. rham-
nosus culture supernatants can decrease expression of ATG14
(autophagy related 14) and BECN1 (beclin 1) as well as the
human papillomavirus early 6 (HPV E6) oncogene, suggesting
that downregulation of HPV E6 by Lactobacillus species may
have therapeutic potential for cervical cancer.11
In conclusion, the publication8 of the Journal of the Chinese
Medical Association brings to mind the reconsideration of the
important interaction between microorganisms and human
beings. Besides use of the human papillomavirus vaccine to
prevent the cervical intraepithelial neoplasm,12 restoration of
good and healthy microbiota environments in human beings
(probiotics)13 might reveal promising prospects for the future.
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